{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:57:56Z","timestamp":1793717876104,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The surgical management of glaucoma associated with Axenfeld-Rieger Syndrome (ARS) is poorly described in the literature. The goal of this study is to compare the effectiveness of various glaucoma surgeries on intraocular pressure (IOP) management in ARS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective cohort study at a university hospital-based practice of patients diagnosed with ARS between 1973 and 2018. Exclusion criterion was follow-up less than 1\u2009year. The number of eyes with glaucoma (IOP\u2009\u2265\u200921\u2009mmHg with corneal edema, Haabs striae, optic nerve cupping or buphthalmos) requiring surgery was determined. The success and survival rates of goniotomy, trabeculotomy\u00b1trabeculectomy (no antifibrotics), cycloablation, trabeculectomy with anti-fibrotics, and glaucoma drainage device placement were assessed. Success was defined as IOP of 5-20\u2009mmHg and no additional IOP-lowering surgery or visually devastating complications. Kaplan-Meier survival curves and the Wilcoxon test were used for statistical analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In 32 patients identified with ARS (median age at presentation 6.9\u2009years, 0\u201358.7\u2009years; median follow-up 5.4\u2009years, 1.1\u201343.7\u2009years), 23 (71.9%) patients were diagnosed with glaucoma at median age 6.3\u2009years (0\u201357.9\u2009years). In glaucomatous eyes (46 eyes), mean IOP at presentation was 21.8\u2009\u00b1\u20099.3\u2009mmHg (median 20\u2009mmHg, 4-45\u2009mmHg) on 1.0\u2009\u00b1\u20091.6 glaucoma medications. Thirty-one eyes of 18 patients required glaucoma surgery with 2.2\u2009\u00b1\u20091.2 IOP-lowering surgeries per eye. Goniotomy (6 eyes) showed 43% success with 4.3\u2009\u00b1\u20093.9\u2009years of IOP control. Trabeculotomy\u00b1trabeculectomy (6 eyes) had 17% success rate with 14.8\u2009\u00b1\u200912.7\u2009years of IOP control. Trabeculectomy with anti-fibrotics (14 eyes) showed 57% success with 16.5\u2009\u00b1\u200913.5\u2009years of IOP control. Ahmed\u00a9 (FP7 or FP8) valve placement (8 eyes) had 25% success rate with 1.7\u2009\u00b1\u20091.9\u2009years of IOP control. Baerveldt\u00a9 (250 or 350) device placement (8 eyes) showed 70% success with 1.9\u2009\u00b1\u20092.3\u2009years of IOP control. Cycloablation (4 eyes) had 33% success rate with 2.7\u2009\u00b1\u20093.5\u2009years of IOP control. At final follow-up, mean IOP (12.6\u2009\u00b1\u20093.8\u2009mmHg, median 11.8\u2009mmHg, 7-19\u2009mmHg) in glaucomatous eyes was significantly decreased (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), but there was no difference in number of glaucoma medications (1.6\u2009\u00b1\u20091.5, <jats:italic>p<\/jats:italic>\u2009=\u20090.1).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In our series, greater than 70% of patients with ARS have secondary glaucoma that often requires multiple surgeries. Trabeculectomy with anti-fibrotics and Baerveldt glaucoma drainage devices showed the greatest success in obtaining IOP control.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01417-w","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T04:17:11Z","timestamp":1588306631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Surgical outcomes of Glaucoma associated with Axenfeld-Rieger syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Emily M.","family":"Zepeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Branham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayoko E.","family":"Moroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Bohnsack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"1417_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0039-6257(85)90205-X","volume":"29","author":"MB Shields","year":"1985","unstructured":"Shields MB, Buckley E, Klintworth GK, Thresher R. Axenfeld-Rieger syndrome. A spectrum of developmental disorders. Surv Ophthalmol. 1985;29:387\u2013409.","journal-title":"Surv Ophthalmol"},{"key":"1417_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0039-6257(75)90034-X","volume":"20","author":"GOI Waring","year":"1975","unstructured":"Waring GOI, Rodrigues MM, Laibson PR. Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol. 1975;20:3\u201327.","journal-title":"Surv Ophthalmol"},{"key":"1417_CR3","first-page":"736","volume":"81","author":"MB Shields","year":"1983","unstructured":"Shields MB. Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc. 1983;81:736\u201384..","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"1417_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/cge.13148","volume":"93","author":"M Seifi","year":"2018","unstructured":"Seifi M, Walter MA. Axenfeld-Rieger syndrome. Clin Genet. 2018;93(6):1123\u201330.","journal-title":"Clin Genet"},{"key":"1417_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/archopht.1966.00970050309003","volume":"75","author":"A Reese","year":"1966","unstructured":"Reese A, Ellsworth A. The anterior chamber cleavage syndrome. Arch Ophthalmol. 1966;75:307\u201318.","journal-title":"Arch Ophthalmol"},{"key":"1417_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bjo.53.7.433","volume":"53","author":"JR Weatherill","year":"1969","unstructured":"Weatherill JR, Hart CT. Familial hypoplasia of the iris stroma associated with glaucoma. Br J Ophthalmol. 1969;53:433\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1417_CR7","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/hmg\/9.14.2131","volume":"9","author":"K Kozlowski","year":"2009","unstructured":"Kozlowski K, Walter MA. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum Mol Genet. 2009;9:2131\u20139.","journal-title":"Hum Mol Genet"},{"key":"1417_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0002-9394(82)90700-0","volume":"93","author":"HM Hittner","year":"1982","unstructured":"Hittner HM, Kretzer FL, Antoszyk JH, Ferrell RE, Mehta RS. Variable expressivity of autosomal dominant anterior segment mesenchymal dysgenesis in six generations. Am J Ophthalmol. 1982;93:57\u201370.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1417_CR9","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0161-6420(96)30408-9","volume":"103","author":"MA Walter","year":"1996","unstructured":"Walter MA, Mirzayans F, Mears AJ, Hickey K, Pearce WG. Autosomal-dominant iridogoniodysgenesis and Axenfeld-Rieger syndrome are genetically distinct. Ophthalmology. 1996;103(11):1907\u201315.","journal-title":"Ophthalmology."},{"issue":"6","key":"1417_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/hmg\/ddl008","volume":"15","author":"FB Berry","year":"2006","unstructured":"Berry FB, Lines MA, Oas JM, et al. Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis. Hum Mol Genet. 2006;15(6):905\u201319.","journal-title":"Hum Mol Genet"},{"key":"1417_CR11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/11.10.1177","volume":"11","author":"MA Lines","year":"2002","unstructured":"Lines MA, Kozlowski K, Walter MA. Molecular genetics of Axenfeld-Rieger malformations. Hum Mol Genet. 2002;11:1177\u201384.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1417_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ng1296-392","volume":"14","author":"EV Semina","year":"1996","unstructured":"Semina EV, Reiter R, Leysens NJ, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet. 1996;14(4):392\u20139.","journal-title":"Nat Genet"},{"issue":"3","key":"1417_CR13","first-page":"613","volume":"59","author":"JC Phillips","year":"1996","unstructured":"Phillips JC, del Bono EA, Haines JL, et al. A second locus for Rieger syndrome maps to chromosome 13q14. Am J Hum Genet. 1996;59(3):613\u20139.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1417_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0002-9394(99)80242-6","volume":"125","author":"WL Alward","year":"1998","unstructured":"Alward WL, Semina EV, Kalenak JW, et al. Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG\/PITX2) gene. Am J Ophthalmol. 1998;125(1):98\u2013100.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1417_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1086\/302109","volume":"63","author":"AJ Mears","year":"1998","unstructured":"Mears AJ, Jordan T, Mirzayans F, et al. Mutations of the forkhead\/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet. 1998;63(5):1316\u201328.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1417_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ejhg.2017.59","volume":"25","author":"E Souzeau","year":"2017","unstructured":"Souzeau E, Siggs OM, Zhou T, et al. Glaucoma spectrum and age-related prevalence of individuals with FOXC1 and PITX2 variants. Eur J Hum Genet. 2017;25(7):839\u201347.","journal-title":"Eur J Hum Genet"},{"key":"1417_CR17","doi-asserted-by":"crossref","unstructured":"Wang X, Liu X, Huang L, et al. Mutation survey of candidate genes and genotype-phenotype analysis in 20 southeastern Chinese patients with Axenfeld-Rieger syndrome. Curr Eye Res. 2018;43(11):1334\u201341.","DOI":"10.1080\/02713683.2018.1493129"},{"key":"1417_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00417-006-0415-2","volume":"245","author":"A Alsheikheh","year":"2007","unstructured":"Alsheikheh A, Klink J, Klink T, Steffen H, Grehn F. Long-term results of surgery in childhood glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007;245:195\u2013203.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1417_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3129\/i09-065","volume":"44","author":"J-F Bussi\u00e8res","year":"2009","unstructured":"Bussi\u00e8res J-F, Therrien R, Hamel P, Pierre B, Prot-Labarthe S. Retrospective cohort study of 163 pediatric glaucoma patients. Can J Ophthalmol. 2009;44:323\u20137.","journal-title":"Can J Ophthalmol"},{"key":"1417_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0161-6420(79)35451-3","volume":"86","author":"MH Luntz","year":"1979","unstructured":"Luntz MH. Congenital, infantile, and juvenile glaucoma. Ophthalmology. 1979;86:793\u2013802.","journal-title":"Ophthalmology."},{"key":"1417_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1442-9071.1977.tb00242.x","volume":"5","author":"NSC Rice","year":"1977","unstructured":"Rice NSC. The surgical management of the congenital glaucomas. Aust J Ophthalmol. 1977;5:174\u20139.","journal-title":"Aust J Ophthalmol"},{"key":"1417_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/eye.2016.66","volume":"30","author":"AK Mandal","year":"2016","unstructured":"Mandal AK, Pehere N. Early-onset glaucoma in Axenfeld-Rieger anomaly: long-term surgical results and visual outcome. Eye. 2016;30:936\u201342.","journal-title":"Eye."},{"key":"1417_CR23","first-page":"501","volume-title":"Chandler and Grant\u2019s Glaucoma","author":"DS Walton","year":"1986","unstructured":"Walton DS. Iridocorneal dysgenesis with glaucoma. In: Epstein DL, editor. Chandler and Grant\u2019s Glaucoma. 3rd ed. Philadelphia: Lea & Febiger; 1986. p. 501\u20135.","edition":"3"},{"key":"1417_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaapos.2017.02.001","volume":"21","author":"C Ozgonul","year":"2017","unstructured":"Ozgonul C, Besirli CG, Bohnsack BL. Combined vitrectomy and glaucoma drainage device implantation surgical approach for complex pediatric glaucomas. J AAPOS. 2017;21:121\u20136.","journal-title":"J AAPOS"},{"key":"1417_CR25","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0161-6420(80)35233-0","volume":"87","author":"SD McPherson","year":"1980","unstructured":"McPherson SD, McFarland D. External trabeculotomy for developmental glaucoma. Ophthalmology. 1980;87:302\u20135.","journal-title":"Ophthalmology."},{"issue":"4","key":"1417_CR26","first-page":"319","volume":"15","author":"W Cadera","year":"1984","unstructured":"Cadera W, Pachtman MA, Cantor LB, Ellis FD, Helveston EM. Filtering surgery in childhood glaucoma. Ophthalmic Surg. 1984;15(4):319\u201322.","journal-title":"Ophthalmic Surg"},{"key":"1417_CR27","first-page":"723","volume":"24","author":"PA Netland","year":"1993","unstructured":"Netland PA, S. WD. Glaucoma drainage implants in pediatric patients. Ophthalmic Surg. 1993;24:723\u20139.","journal-title":"Ophthalmic Surg"},{"issue":"4","key":"1417_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1067\/mpa.2001.116868","volume":"5","author":"DE Neely","year":"2001","unstructured":"Neely DE, Plager DA. Endocyclophotocoagulation for management of difficult pediatric glaucomas. J AAPOS. 2001;5(4):221\u20139.","journal-title":"J AAPOS."},{"issue":"4","key":"1417_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/IJG.0000000000000370","volume":"26","author":"JD Levinson","year":"2017","unstructured":"Levinson JD, Giangiacomo AL, Beck AD, et al. A comparison of sequential glaucoma drainage device implantation versus cyclophotocoagulation following failure of a primary drainage device. J Glaucoma. 2017;26(4):311\u20134.","journal-title":"J Glaucoma"},{"key":"1417_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ajoc.2018.03.009","volume":"10","author":"GR Wang","year":"2018","unstructured":"Wang GR, Thuente D, Bohnsack BL. Angle closure glaucoma in congenital ectropion uvea. Am J Ophthamol Case Rep. 2018;10:215\u201320.","journal-title":"Am J Ophthamol Case Rep"},{"issue":"1","key":"1417_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajo.2012.07.008","volume":"155","author":"BL Bohnsack","year":"2013","unstructured":"Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol. 2013;155(1):134\u201342.","journal-title":"Am J Ophthalmol"},{"key":"1417_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3928\/0191-3913-19890101-03","volume":"26","author":"F Billson","year":"1989","unstructured":"Billson F, Thomas R, Aylward W. The use of two-stage Molteno implants in developmental glaucoma. J Pediatr Ophthalmol Strabismus. 1989;26:3\u20138.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1417_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1442-9071.1986.tb00470.x","volume":"14","author":"AC Molteno","year":"1986","unstructured":"Molteno AC, Pokinghorne PJ, Bowbyes JA. The vicryl tie technique for inserting a draining implant in the treatment of secondary glaucoma. Aust N Z J Ophthlamol. 1986;14:343\u201354.","journal-title":"Aust N Z J Ophthlamol"},{"issue":"1","key":"1417_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1076\/opge.25.1.57.29002","volume":"25","author":"BP Brooks","year":"2004","unstructured":"Brooks BP, Moroi SE, Downs CA, et al. A novel mutation in the PITX2 gene in a family with Axenfeld-Rieger syndrom. Ophthalmic Genet. 2004;25(1):57\u201362.","journal-title":"Ophthalmic Genet"},{"key":"1417_CR35","doi-asserted-by":"crossref","unstructured":"Luebke J, Neuburger M, Jordan JF, et al. Bleb-related infections and long-term follow-up after trabeculectomy. Int Ophthalmol. 2018;39(3):571\u20137.","DOI":"10.1007\/s10792-018-0851-0"},{"issue":"5","key":"1417_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.survophthal.2017.01.009","volume":"62","author":"MR Razeghinejad","year":"2017","unstructured":"Razeghinejad MR, Havens SJ, Katz LJ. Trabeculectomy bleb-associated infections. Surv Ophthalmol. 2017;62(5):591\u2013610.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"1417_CR37","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/S0161-6420(03)00800-5","volume":"110","author":"AP Wells","year":"2003","unstructured":"Wells AP, Cordeiro MF, Bunce C, Khaw PT. Cystic bleb formation and related complications in limbus-versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology. 2003;110(11):2192\u20137.","journal-title":"Ophthalmology."},{"issue":"5","key":"1417_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0002-9394(98)00227-X","volume":"126","author":"AD Beck","year":"1988","unstructured":"Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R. Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol. 1988;126(5):648\u201357.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1417_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12886-018-0709-2","volume":"18","author":"TJ Kim","year":"2018","unstructured":"Kim TJ, Kang S, Jeoung JW, Kim YK, Park KH. Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant. BMC Ophthalmol. 2018;18(1):45.","journal-title":"BMC Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01417-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:27:45Z","timestamp":1620044865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01417-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"2 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the Health Sciences and Behavioral Sciences Institutional Review Board of the University of Michigan.This study was approved as exempt by the Institutional Review Board at the University of Michigan due to the retrospective nature of the study and the lack of identifiable data. Thus, no patient consents were required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}